HCW Biologics Inc. (HCWB) — 分析师展望 / 分析师共识目标价为. 基于 3 位分析师评级, 共识为 看涨 — 3 买入.
分析师预估 每股收益(EPS)为 $-22.80 和 营收为 $0.01B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.77 vs 预期 $-22.80 (超预期 +96.6%). 2025: 实际 $-10.63 vs 预期 $-5.23 (不及预期 -103.3%). 分析师准确度: 0%.
HCWB 分析师评级
Buy
基于过去3个月内 3 位分析师对 HCW Biologics Inc. 的评级
EPS 预测 — HCWB
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.77
vs Est –$22.80
▲ 2,861.0% off
2025
Actual –$10.63
vs Est –$5.23
▼ 50.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — HCWB
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.003B
vs Est $0.009B
▼ 257.3% off
2025
Actual $0.000B
vs Est $0.000B
▲ 50.2% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
